← Leaderboards
Eunyoung Park
Dana-Farber Cancer Inst
$942,065
Attributed
$942,065
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $188.4K · FY2017–21$200K$150K$100K$50K$0
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$942,065 · 1
By mechanism
R50$942,065 · 1
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Nathanael Schiander Gray$36,761,550
- Michael J Eck$25,871,961
- Alice Berger$5,749,854
- Jun Qi$6,834,111
- Franziska Michor$16,040,992
Others in their field
Other Emerging Leaders on “Automobile Driving”
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- Susan Abushakra · Alzheon, Inc.$47,690,244
- Scott Topper · Broad Institute, Inc.$30,147,501
- Leonard Freedman · Leidos Biomedical Research, Inc.$15,624,898
- Ganesh M Babulal · Washington University$11,062,209
- Christopher A. Gaiteri · Rush University Medical Center$9,886,289
Research focus
Automobile DrivingBraf GeneCancer EtiologyCancer TherapyChildhood Malignant Brain TumorDana-Farber Cancer InstituteDrug DiscoveryDrug ResistanceDrug TargetingEnzyme KineticsEpidermal Growth Factor ReceptorEpidermal Growth Factor Receptor Tyrosine Kinase InhibitorExonsInhibitor/AntagonistInsightInterestLaboratoriesLeadLigand BindingLigandsLongitudinal StudiesLung AdenocarcinomaMalignant NeoplasmsArea
Grant awards (5)
Structural biology and drug discovery targeting oncogenic EGFR and BRAF kinases$188,413
R50 · FY2021 · CA · contact PI
Structural biology and drug discovery targeting oncogenic EGFR and BRAF kinases$188,413
R50 · FY2020 · CA · contact PI
Structural biology and drug discovery targeting oncogenic EGFR and BRAF kinases$188,413
R50 · FY2019 · CA · contact PI
Structural biology and drug discovery targeting oncogenic EGFR and BRAF kinases$188,413
R50 · FY2018 · CA · contact PI
Structural biology and drug discovery targeting oncogenic EGFR and BRAF kinases$188,413
R50 · FY2017 · CA · contact PI